Follow The Filings

BWXT BWX Technologies Inc.

Industrials, filed as BWX TECHNOLOGIES INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 1

  • 1 Owner
  • #285
  • Max 0.3%
  • Master 0.01%
  • $2.3M
  • 1 add

In 2026 Q3 Torray Investment Partners added to BWX Technologies.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Add 0.30%

Who owns BWXT

Sorted by value, long equity only, as of 2026 Q3.

History
Torray Investment Partners 0.30% Add +31.3% 16,585 $2.3M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BWXT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BWXT insider trades
  • None no insider bought on the open market
  • $1.2M sold by 3 insiders outside a trading plan
  • $7.8M sold by 1 insider under 10b5-1 plans
  1. Rex D Geveden CEO
    Planned sale
    $1.7M 10,000 shares at $172.50 4.9% of stake
    Traded Aug 12 Filed Aug 13
  2. Rex D Geveden CEO
    Planned sale
    $2M 10,000 shares at $204.81 4.7% of stake
    Traded May 12 Filed May 12
  3. Michael Thomas Fitzgerald CFO
    Sale
    $506K 2,417 shares at $209.25 26% of stake
    Traded May 11 Filed May 12
  4. Kevin James Gorman VP & Chief Accounting Officer
    Sale
    $289K 1,344 shares at $214.71 92% of stake
    Traded Mar 2 Filed Mar 4
  5. Gerhard F Burbach Director
    Sale
    $414K 1,983 shares at $208.61 100% of stake
    Traded Feb 25 Filed Feb 27
  6. Rex D Geveden CEO
    Planned sale
    $2M 10,000 shares at $203.26 5.3% of stake
    Traded Feb 12 Filed Feb 13
  7. Rex D Geveden CEO
    Planned sale
    $2M 10,000 shares at $197.90 5.1% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises, 23 share withholdings for taxes, and 1 stock grant.

Congress

2 members of Congress traded BWXT in the last three years: 10 buys and 3 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $100K–$250K Aug 25 filed Sep 9
  2. April McClain Delaney D-MD-6Child Buy $1K–$15K Aug 3 filed Sep 9
  3. April McClain Delaney D-MD-6Child Buy $1K–$15K Jul 30 filed Aug 3
  4. April McClain Delaney D-MD-6Child Buy $1K–$15K Jul 27 filed Aug 3
  5. April McClain Delaney D-MD-6Child Buy $15K–$50K Jul 24 filed Aug 3
  6. April McClain Delaney D-MD-6Child Buy $15K–$50K May 15 filed Jun 5

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
10-Q/A
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.5B $2.7B $3.2B
Gross profit * $620.59M $655.21M $732.86M
Gross margin * 24.9% 24.2% 22.9%
Net income $245.85M $281.94M $328.94M
Net margin * 9.8% 10.4% 10.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.818B $0.93B $1.56B
Total non-current assets * $1.93B $1.94B $2.71B
Total assets $2.75B $2.87B $4.27B
Total current liabilities $375.05M $474.2M $672.02M
Total non-current liabilities * — — $2.37B
Total equity $0.933B $1.08B $1.23B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $363.7M $408.43M $479.85M
Cash from investing -$155.64M -$154.56M -$742.11M
Cash from financing -$169.37M -$252.78M $693.64M
Net change in cash $40.62M -$1.04M $426.63M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.